noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

McCarthy Building Companies Inc.

How a Total Project Life Cycle Mindset Can Benefit Your Next Project
Waste Management Inc.

WM Sets Date for First Quarter Earnings Release Conference Call
Fresno Yosemite International Airport

Helpful Tips for Spring Break Travel

Healthcare

Moderna Inc.

01/30/2023 | Press release | Distributed by Public on 01/30/2023 06:28

Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Moderna Inc. | News | Health | Science | Research | Politics and Policy | Policy and Regulation | Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Wiener Börse (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | Budapest Stock Exchange | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Bolsa Institucional de Valores (BIVA) | Hannover Stock Exchange | Nasdaq BX | Nasdaq PSX | NYSE Chicago

Back